House lawmaker raises new concerns over FDA's ultra-fast drug review program
A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs. The initiative by FDA Commissioner Marty Makary promises ultra-fast reviews for drugs that align with “national priorities.” But the effort has become a flashpoint for controversy outside and inside the agency. Rep. Jake Auchincloss of Massachusetts sent a letter Tuesday questioning the legal underpinning of the program and asserting that the agency... Читать дальше...